We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tyratech (DI) | LSE:TYRU | London | Ordinary Share | COM SHS USD0.001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.00 | 2.80 | 3.20 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/10/2017 01:44 | Just looking at the SAR's that were issued and I notice the 2m issued on 13/04/2016 vested in April of this year... What really caught my eye was the exercise price, 3.75p. Clearly those in charge weren't expecting the share price to be languishing at 1.5p mid price 6 months after the vested date. It's worth noting that since those SAR's were issued OutSmart has come to market, as has the product for red mites and we've had the $500k from the Envance deal. With some kind of reorganisation just around the corner Tyratech looks to be worth a punt. | michaelsadvfn | |
05/10/2017 09:25 | So yesterday's net 80k bought resulted in a 16% drop in the published bid. That's about normal for this share. Real bid 1.424 for 250k. | michaelsadvfn | |
04/10/2017 13:25 | I had presumed that it was,michaelsadvfn. Speculative short term punters are being hung out to dry as they attempt to close their positions. Tyratech's share price remains on the way up imo. | mudbath | |
04/10/2017 12:31 | That was me mudbath, the author needed to be corrected, and why not give Tyratech a plug at the same time ;-) Another depressing day for this share. The quoted prices for TYR & TYRU are nowhere near reality given the mm's close down online trading at every turn. | michaelsadvfn | |
04/10/2017 10:03 | michaelsadvfn. Thanks for those three postings. We(Tyratech and Investors)are in the calm before the storm,imo. The portents for an exceptional future performance are there for all to see. Interestingly,shortl "Martin Bird 3 Oct 15:47 'Only North America is currently free from mite...' IT IS NOT !! There's a small company, TyraTech, operating out of Morrisville, NC that has come up with a natural solution to the problem of red mites. Based on plant extracts it will eradicate 95% of mites on first contact and continue to work on the remainder. The product has been field tested and has been accepted by the largest producers of chickens and eggs in the USA - Cal-Maine, Perdue, Tyson & Rose Acre. Field trials in Europe(France) have produced the same excellent results. Get in there Martin !! | mudbath | |
03/10/2017 13:07 | Prof Sparagano said latest figures suggested the total annual cost of poultry med mite infestations in the European egg laying industry is estimated to be €231m and €3.2bn worldwide.(note that's just the egg laying industry) He urged the International Egg Commission to set up a working group on red mite, saying the growing resistance to Carbaryl and Permethrin based insecticides meant there were not many solutions available. This was leading to products from the black market being used, as seen in the recent fraud case involving Fipronil... The 2 comments at the end made me chuckle. | michaelsadvfn | |
03/10/2017 12:55 | In Germany, there are only about 2-3 products that show good efficacy and sometimes we need to change the products because of resistance issues. We do a lot with silica dust for prevention but may use the chemicals as well, trying to save them for as late as possible. But the big gap is that there are only 2-3 products with good efficacy. Red mites = big problem. What if a company came along with a product that eradicated 95% of mites on first application and continued working over time on the remaining 5%? Hang on a minute.... | michaelsadvfn | |
03/10/2017 10:05 | Listening to the last interview with BJ it would appear that the red mite product will be launched in Europe after the restructuring of the company. He says as much from 6'30 to 7'30... ..what we need now is to finish the reorganisation of the company that would allow us to move forwards with launching products on the AH side... It would also make sense to offer the red mite product to any prospective partner as we have no European distribution channel as things stand. MWI is USA only. I'd expect to hear something before we reach December if they're planning to have this completed before the end of the year. | michaelsadvfn | |
02/10/2017 20:20 | Wouldn't mind a peek at this report but it's out of my budget.... I was fishing around for AH distributors in Europe(MWI is USA only). | michaelsadvfn | |
02/10/2017 13:00 | Good news cant be too far off now. | encarter | |
02/10/2017 12:56 | michaelsadvfn 28 Sep '17 - 10:50 - 2401 of 2408 Buying has totally dried up, next move will be 1.75 on the offer. Bottom drawer for these until the next update. QED. Not a single buy trade during the last week. | michaelsadvfn | |
01/10/2017 11:35 | PERMETHRIN is not very effective as lice are resistant to it .that is in lyclear creme rinse. haven't come across rid or nix lice products in UK. there is a nix stick for stopping bleeding from razor nicks that I sell that is effective.it does however sting when applied. | haroldthegreat | |
01/10/2017 11:22 | Mudbath I hope octopus did not buy at 10p.I am concerned about Nobby not posting as he offered to buy all my unsold vamousse stock.; | haroldthegreat | |
01/10/2017 11:11 | Derbac is hardly used in UK because of resistance and contains an organophosphorous insecticide as a pesticide. I haven't received a prescription for that for many years .and when i did it was for scabies and pubic lice. These type of products are still used in the states and because of resistance don't work. that is why vamousse is concentrating on the us market. similarly I haven't received a script or OTC request for vamousse either. As a continual poster on vamousse I am surprised you have never heard of derbac michael ! Whenever I read Which reports I normally find them to be factual and unbiased.I will try to read the lice one when I can get access to it. | haroldthegreat | |
01/10/2017 10:36 | Octopus Investments Holders of 19.91% of the Tyratech equity. "Octopus invest in the ideas, people and enterprises that might one day change the world." | mudbath | |
30/9/2017 16:40 | That's rather unfair if I may say so skip10. Why didn't you just say there was no mention of RID or NIX instead of choosing to pick on Vamousse? Rubbish article anyway as they only cover Full Marks, Lyclear, Hedrin and Derbac, which I've never heard of. The first 3 are chemical based and do not work. £10.75/month for a subscription? I'll pass on that as well. | michaelsadvfn | |
30/9/2017 11:16 | Primae facie, that sounds terrible. Explanation ? | corrientes | |
30/9/2017 11:11 | "Which?" has just done a review of current head lice and nit treatments. Not a mention of Vamousse. | skip10 | |
28/9/2017 10:50 | Buying has totally dried up, next move will be 1.75 on the offer. Bottom drawer for these until the next update. | michaelsadvfn | |
27/9/2017 20:39 | The chart points to consolidation around 2p for a few weeks. While you wait take a look at PRS. I’ve posted some exciting research on the bb. | cliley454 | |
27/9/2017 10:45 | 1.59____2.59____3.59 ? Pass,pass and pass again. | mudbath | |
27/9/2017 10:04 | They'll take 250k(£4k's worth) from you. 1.59? Pass. | michaelsadvfn | |
27/9/2017 08:39 | Nobby where are you? No posting to pump the shares ? No reports on vamousse sales at your local pharmacy. Have you sold out and are no longer interested ? No you must have abducted by aliens! The chart shows a 10% drop since you haven't posted. If you don't put any effort in they may go back to 1p If u do not want to put the reason on line send a private message. | haroldthegreat | |
26/9/2017 21:17 | I havn't got enough fingers to answer that question,michaelsadv (Eventually) | mudbath |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions